UNSPSC 51422214: Triamcinolone benetonide

This classification denotes a therapeutic glucocorticoid C35H42FNO8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9DXL8A82MI, chemically known as 9-fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone 21-ester with n-benzoyl-2-methyl-.beta.-alanine, but more generally known as triamcinolone benetonide, which bears US NIH Compound Identifier 62963.

UNSPSC 51422214 Triamcinolone benetonide is a Commodity code with no relevant recent state and local procurement activity. The two recent opportunities tagged to this code—Seminole County's IFB for Naloxone and Safe Drug Deactivation Systems (IFB60459723LAS, due Jul 26, 2023) and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs (HHS0017013, posted Apr 3, 2026)—are unrelated to triamcinolone benetonide, a topical corticosteroid medication. The Seminole County solicitation targets opioid-reversal and drug-deactivation equipment, and the Texas HHS RFI addresses pharmacy benefit program contracting structures; neither addresses the specific pharmaceutical ingredient or therapeutic use this code nominally describes. The mismatch suggests either a tagging error in the source data or that state and local procurement under this code operates outside current monitored channels.

Without verified recent opportunities aligned to the code's actual scope, pursuing activity under UNSPSC 51422214 carries significant execution risk. Business development professionals should clarify with state and local procurement offices whether triamcinolone benetonide purchases are routed through alternative code structures, group purchasing organizations, or cooperative agreements not yet visible in the current posting cycle, or whether demand for this specific ingredient remains minimal in the state and local market segment.